IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1119 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Metabolic syndrome in antipsychotic na´ve patients with schizophrenia: pooled analysis of data from three Indian studies
Sandeep Grover,Naresh Nebhinani,Ramachandran Padmavati,Rakesh K Chadda,Srinivasan Tirupati,Abhishek Pallava
Early Intervention in Psychiatry.2015;9(5)357
[DOI]
2A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia
Nidhi Malhotra,Parmanand Kulhara,Subho Chakrabarti,Sandeep Grover
Journal of Affective Disorders.2013;150(2)653
[DOI]
3Mental Health Nurses' Knowledge of Clozapine
Sujatha Sanjeevi,Angela Cocoman
Issues in Mental Health Nursing.2021;42(3)291
[DOI]
4Clozapine research from India: A systematic review
Sandeep Grover,Sanjana Kathiravan
Asian Journal of Psychiatry.2023;79(3)103353
[DOI]
5METABOLIC SYNDROME IN PATIENTS WITH PSYCHOSIS USING SECOND-GENERATION ANTIPSYCHOTICS
Sarath Chandra Ivaturi,Sri Ramya,Syed Zainab
PARIPEX INDIAN JOURNAL OF RESEARCH.2022;79(3)33
[DOI]
6Does the Starting of Clozapine Influence Coprescription of Other Medications?
Sandeep Grover,Chandrima Naskar,Subho Chakrabarti
Journal of Clinical Psychopharmacology.2021;41(2)148
[DOI]
7Metabolic syndrome in antipsychotic na´ve patients diagnosed with schizophrenia
Sandeep Grover,Naresh Nebhinani,Subho Chakrabarti,Preeti Parakh,Deepak Ghormode
Early Intervention in Psychiatry.2012;6(3)326
[DOI]
8Seventy Years of Antipsychotic Development: A Critical Review
Mujeeb U. Shad
Biomedicines.2023;11(1)130
[DOI]
9Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
Marius H. Sneller,Nini de Boer,Sophie Everaars,Max Schuurmans,Sinan Guloksuz,Wiepke Cahn,Jurjen J. Luykx
Frontiers in Psychiatry.2021;12(1)130
[DOI]
10Relationship of metabolic syndrome and neurocognitive deficits in patients with schizophrenia
Sandeep Grover,Padmavati R,Swapnajeet Sahoo,Subhashini Gopal,Ritu Nehra,Arthi Ganesh,Vijaya Raghavan,Anoop Sankaranarayan
Psychiatry Research.2019;278(1)56
[DOI]
11Metabolic syndrome in drug na´ve patients with substance use disorder
Manish Bathla,Manpreet Singh,Shazia Anjum,Parmanand Kulhara,Satyarth Jangli
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2017;11(3)167
[DOI]
12Leukocyte telomere length in Hispanic schizophrenia patients under treatment with olanzapine
Nancy Monroy-Jaramillo,Yaneth RodrÝguez-Agudelo,Luis Carlos Avi˝a-Cervantes,David L. Roberts,Dawn I. Velligan,Consuelo Walss-Bass
Journal of Psychiatric Research.2017;90(3)26
[DOI]
13Prevalence of metabolic syndrome in bipolar disorder: An exploratory study from North India
Sandeep Grover,Munish Aggarwal,Subho Chakrabarti,Alakananda Dutt,Ajit Avasthi,Parmanand Kulhara,Nidhi Malhotra,Mansi Somaiya,Nidhi Chauhan
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2012;36(1)141
[DOI]
14Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from North India
Sandeep Grover,Naresh Nebhinani,Subho Chakrabarti,Ajit Avasthi,Parmanand Kulhara,Debasish Basu,Surendra Kumar Mattoo,Savita Malhotra
Nordic Journal of Psychiatry.2014;68(1)72
[DOI]
15Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile andátreatment outcomes for clients on clozapine
Dominiek Coates,Patricia Woodford,Oliver Higgins,Deborah Grover
International Journal of Mental Health Nursing.2018;27(1)303
[DOI]
16Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile andátreatment outcomes for clients on clozapine
Sandeep Grover,Harsh Garekar,Anisha Agarwal
International Journal of Mental Health Nursing.2019;27(1)109
[DOI]
17Disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy
Dhandapani Nandakumar,Ragul Ganesh,Koushik S. Deb,Raka Jain,Mamta Sood
Indian Journal of Psychiatry.2023;65(6)694
[DOI]
18Prevalence of metabolic syndrome in patients with schizophrenia in India
Sandeep Grover,Munish Aggarwal,Alakananda Dutt,Subho Chakrabarti,Ajit Avasthi,Parmanand Kulhara,Mansi Somaiya,Nidhi Malhotra,Nidhi Chauhan
Psychiatry Research.2012;200(2-3)1035
[DOI]
19Prescription practices and attitude of psychiatrists towards clozapine: A survey of psychiatrists from India
Sandeep Grover,Srinivas Balachander,Subho Chakarabarti,Ajit Avasthi
Asian Journal of Psychiatry.2015;18(2-3)57
[DOI]
20Effectiveness of clozapine on quality of life and functioning in patients with treatment-resistant schizophrenia
Meha Verma,Sandeep Grover,Subho Chakrabarti
Nordic Journal of Psychiatry.2021;75(2)135
[DOI]
21A meta-analysis of cardio-metabolic abnormalities in drug na´ve, first-episode and multi-episode patients with schizophrenia versus general population controls
Davy Vancampfort,Martien Wampers,Alex J. Mitchell,Christoph U. Correll,Amber De Herdt,Michel Probst,Marc De Hert
World Psychiatry.2013;12(3)240
[DOI]
22Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus
Sandeep Grover,Meha Verma,Subho Chakrabarti
Journal of Clinical Psychopharmacology.2020;40(3)276
[DOI]
23Cost of the Illness of Treatment-Resistant Schizophrenia
Meha Verma,Sandeep Grover,Subho Chakrabarti
Journal of Clinical Psychopharmacology.2021;41(1)36
[DOI]
24Metabolic Syndrome in Adults Receiving Clozapine; The Need for Pharmacist Support
Kathleen Hurley,Sinead OĺBrien,Ciaran Halleran,Derina Byrne,Erin Foley,Jessica Cunningham,Fionnuala Hoctor,Laura J. Sahm
Pharmacy.2023;11(1)23
[DOI]
25Effect of clozapine on psychological outcomes of caregivers of patients with treatment resistant schizophrenia
Meha Verma,Sandeep Grover,Subho Chakrabarti
Nordic Journal of Psychiatry.2021;75(2)118
[DOI]
26Effect of clozapine on psychological outcomes of caregivers of patients with treatment resistant schizophrenia
Parmanand Kulhara,Sandeep Grover,Natasha Kate
Nordic Journal of Psychiatry.2015;75(2)173
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow